Additional Metadata
Persistent URL dx.doi.org/10.1056/NEJMc1814750, hdl.handle.net/1765/113488
Journal New England Journal of Medicine
Citation
Coebergh van den Braak, R.R.J, Martens, J.W.M, & IJzermans, J.N.M. (2018). Correction to our Letter to the Editor about "CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer". New England Journal of Medicine, 379(25). doi:10.1056/NEJMc1814750